Estetrol
| E4 | |
|---|---|
| Salts [] | |
|---|---|
| Estetrol monohydrate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 304.40 g/mol [1] |
| Melting point | 233-236 [1] |
| Boiling point | 491.9±45.0 [1] |
| Predicted LogP | 1.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C18H24O4 |
| IUPAC name | (8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol |
| SMILES | C[C@]12CC[C@H]3[C@H]([C@@H]1[C@H]([C@H]([C@@H]2O)O)O)CCC4=C3C=CC(=C4)O |
| InChI | InChI=1S/C18H24O4/c1-18-7-6-12-11-5-3-10(19)8-9(11)2-4-13(12)14(18)15(20)16(21)17(18)22/h3,5,8,12-17,19-22H,2,4,6-7H2,1H3/t12-,13-,14-,15-,16-,17+,18+/m1/s1 |
| InChIKey | AJIPIJNNOJSSQC-NYLIRDPKSA-N |
| CAS number | 15183-37-6 |
| UNII | ENB39R14VF |
| PubChem CID | 27125 |
Estetrol (also known as Estetrol anhydrous, 15α-hydroxyestriol, estetrolum, oestetrol, Estetrol (anhydrous), 15 α-hydroxyestriol, estra-1,3,5(10)-triene-3,15α,16α,17β-tetrol, Estra-1,3,5(10)-triene-3,15,16,17-tetrol, (15α,16α,17β)-, 15 α Hydroxyestriol or 15 α Hydroxy Estriol) is a substance of the phenol and steroid class.
Chemistry
Salts []
Stereochemistry []
Estetrol is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Estetrol matches Lipinski's rule of five.Pharmacology
ATC Classification
- genito urinary system and sex hormones (G)
- sex hormones and modulators of the genital system (G03)
- estrogens (G03C)
- natural and semisynthetic estrogens, plain (G03CA)
- estetrol (G03CA10)
Mechanism of action []
Estetrol is a synthetic analogue of a naturally occurring estrogen present during pregnancy, demonstrating selectivity for both estrogen receptor-α (ER-α) and ER-β and suppressing ovulation. Estetrol binds with a low to moderate affinity human estrogen receptor alpha (ER alpha) and ER beta with a preference for ER alpha. Estetrol demonstrates a unique mechanism of action via tissue selective activity, showing estrogen receptor agonist activity on the vagina, the uterus and the endometrium, and negative estrogenic activity on breast tissue. [1]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 27125, Estetrol. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/27125
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Estetrol. UNII: ENB39R14VF. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/ENB39R14VF
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 13:54:32 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 13:54:28 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 13:54:28 |
| gsrs | ok | 2026-11-20 13:54:30 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0304837) | 2026-11-20 13:54:28 |
| kegg | ok | 2026-11-20 13:54:31 |
| pubchem | ok | 2026-11-20 13:54:28 |
| missing (no r/tripreports posts mention it) | 2026-11-20 13:54:28 | |
| sider | missing (not in SIDER) | 2026-11-20 13:54:28 |
| structure | ok | 2026-11-20 13:54:28 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 13:54:29 |